Citadel Advisors - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 85 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,443,889
-40.6%
140,115
-25.8%
0.00%
-50.0%
Q2 2023$10,853,209
+619.2%
188,850
+369.3%
0.00%
Q1 2023$1,509,038
+3.4%
40,241
-22.8%
0.00%
Q4 2022$1,460,039
-73.6%
52,107
-73.5%
0.00%
-100.0%
Q3 2022$5,521,000
+82.2%
196,465
+125.6%
0.00%
Q2 2022$3,030,000
-67.6%
87,098
-66.6%
0.00%
-100.0%
Q1 2022$9,363,000
+88.3%
260,783
+22.1%
0.00%
+100.0%
Q4 2021$4,973,000
+910.8%
213,522
+776.1%
0.00%
Q2 2021$492,000
-47.8%
24,373
-52.6%
0.00%
Q1 2021$942,000
-33.2%
51,429
-26.7%
0.00%
Q4 2020$1,410,000
+39.3%
70,138
+29.9%
0.00%
Q3 2020$1,012,000
-16.4%
53,974
+0.2%
0.00%
Q2 2020$1,210,000
-5.5%
53,840
-37.6%
0.00%
-100.0%
Q1 2020$1,280,000
-51.1%
86,215
-34.7%
0.00%0.0%
Q3 2019$2,618,000
+116.5%
132,053
+130.5%
0.00%0.0%
Q2 2019$1,209,000
+137.1%
57,286
+129.5%
0.00%
Q1 2019$510,000
-19.9%
24,960
-22.0%
0.00%
Q4 2018$637,000
-0.6%
32,014
-6.3%
0.00%
Q1 2018$641,000
-61.2%
34,180
-63.1%
0.00%
-100.0%
Q2 2017$1,653,000
-67.9%
92,576
-74.0%
0.00%
-80.0%
Q1 2017$5,156,000
+1412.0%
355,566
+1823.3%
0.01%
Q4 2016$341,000
-72.8%
18,487
-72.0%
0.00%
-100.0%
Q3 2016$1,254,000
-63.9%
66,120
-69.3%
0.00%
-75.0%
Q2 2016$3,469,000
+2243.9%
215,231
+1640.1%
0.00%
Q1 2016$148,000
+0.7%
12,369
+19.7%
0.00%
Q4 2015$147,000
-88.6%
10,336
-86.0%
0.00%
-100.0%
Q2 2015$1,295,000
+48.9%
73,670
+26.7%
0.00%0.0%
Q1 2015$870,000
+48.7%
58,162
+15.4%
0.00%0.0%
Q4 2014$585,000
+219.7%
50,384
+220.9%
0.00%
Q3 2014$183,00015,7000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders